NCT00219609

Brief Summary

To determine whether UK-390,957 is a safe treatment for premature ejaculation.

Trial Health

98
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,058

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Jan 2005

Shorter than P25 for phase_2

Geographic Reach
13 countries

77 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2005

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

September 9, 2005

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 22, 2005

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2006

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2006

Completed
Last Updated

November 7, 2012

Status Verified

November 1, 2012

Enrollment Period

1.2 years

First QC Date

September 9, 2005

Last Update Submit

November 5, 2012

Conditions

Ejaculation

Outcome Measures

Primary Outcomes (1)

  • Assessment of safety

Interventions

UK-390,957DRUG

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects will have completed one of the phase 2 trials (A3871022/ A3871027/ A3871029) and will have met the diagnostic criteria for premature ejaculation as defined by DSM-IV

You may not qualify if:

  • No drug related serious adverse events

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (82)

Pfizer Investigational Site

Tucson, Arizona, United States

Location

Pfizer Investigational Site

Anaheim, California, United States

Location

Pfizer Investigational Site

Atherton, California, United States

Location

Pfizer Investigational Site

Beverly Hills, California, United States

Location

Pfizer Investigational Site

Laguna Woods, California, United States

Location

Pfizer Investigational Site

Newport Beach, California, United States

Location

Pfizer Investigational Site

Redwood City, California, United States

Location

Pfizer Investigational Site

San Diego, California, United States

Location

Pfizer Investigational Site

Tarzana, California, United States

Location

Pfizer Investigational Site

Walnut Creek, California, United States

Location

Pfizer Investigational Site

Aurora, Colorado, United States

Location

Pfizer Investigational Site

Waterbury, Connecticut, United States

Location

Pfizer Investigational Site

Aventura, Florida, United States

Location

Pfizer Investigational Site

New Port Richey, Florida, United States

Location

Pfizer Investigational Site

Evansville, Indiana, United States

Location

Pfizer Investigational Site

Fort Wayne, Indiana, United States

Location

Pfizer Investigational Site

Indianapolis, Indiana, United States

Location

Pfizer Investigational Site

Lexington, Kentucky, United States

Location

Pfizer Investigational Site

Madisonville, Kentucky, United States

Location

Pfizer Investigational Site

Metairie, Louisiana, United States

Location

Pfizer Investigational Site

Watertown, Massachusetts, United States

Location

Pfizer Investigational Site

Saint Clair Shores, Michigan, United States

Location

Pfizer Investigational Site

Minneapolis, Minnesota, United States

Location

Pfizer Investigational Site

Southhaven, Mississippi, United States

Location

Pfizer Investigational Site

Kansas City, Missouri, United States

Location

Pfizer Investigational Site

Edison, New Jersey, United States

Location

Pfizer Investigational Site

New Brunswick, New Jersey, United States

Location

Pfizer Investigational Site

Vorhees, New Jersey, United States

Location

Pfizer Investigational Site

Albany, New York, United States

Location

Pfizer Investigational Site

Endwell, New York, United States

Location

Pfizer Investigational Site

New York, New York, United States

Location

Pfizer Investigational Site

West Seneca, New York, United States

Location

Pfizer Investigational Site

Williamsville, New York, United States

Location

Pfizer Investigational Site

Charlotte, North Carolina, United States

Location

Pfizer Investigational Site

Durham, North Carolina, United States

Location

Pfizer Investigational Site

Beachwood, Ohio, United States

Location

Pfizer Investigational Site

Portland, Oregon, United States

Location

Pfizer Investigational Site

Germantown, Tennessee, United States

Location

Pfizer Investigational Site

Knoxville, Tennessee, United States

Location

Pfizer Investigational Site

Memphis, Tennessee, United States

Location

Pfizer Investigational Site

Milan, Tennessee, United States

Location

Pfizer Investigational Site

Dallas, Texas, United States

Location

Pfizer Investigational Site

Houston, Texas, United States

Location

Pfizer Investigational Site

San Antonio, Texas, United States

Location

Pfizer Investigational Site

Milwaukee, Wisconsin, United States

Location

Pfizer Investigational Site

Milwuakee, Wisconsin, United States

Location

Pfizer Investigational Site

St Leonards, New South Wales, Australia

Location

Pfizer Investigational Site

Spring Hill, Queensland, Australia

Location

Pfizer Investigational Site

Adelaide, South Australia, Australia

Location

Pfizer Investigational Site

Malvern, Victoria, Australia

Location

Pfizer Investigational Site

Nedlands, Western Australia, Australia

Location

Pfizer Investigational Site

Mistelbach, Austria

Location

Pfizer Investigational Site

Salzburg, Austria

Location

Pfizer Investigational Site

Barrie, Ontario, Canada

Location

Pfizer Investigational Site

London, Ontario, Canada

Location

Pfizer Investigational Site

Oakville, Ontario, Canada

Location

Pfizer Investigational Site

Toronto, Ontario, Canada

Location

Pfizer Investigational Site

Montréal, Quebec, Canada

Location

Pfizer Investigational Site

Montreal, Quebec, Canada

Location

Pfizer Investigational Site

Brno, Czechia

Location

Pfizer Investigational Site

Prague, Czechia

Location

Pfizer Investigational Site

Lyon, France

Location

Pfizer Investigational Site

Hamburg, Germany

Location

Pfizer Investigational Site

Hanover, Germany

Location

Pfizer Investigational Site

München, Germany

Location

Pfizer Investigational Site

Beersheba, Israel

Location

Pfizer Investigational Site

Haifa, Israel

Location

Pfizer Investigational Site

Tel Aviv, Israel

Location

Pfizer Investigational Site

Tel Litwinsky, Israel

Location

Pfizer Investigational Site

Milan, Italy

Location

Pfizer Investigational Site

Roma, Italy

Location

Pfizer Investigational Site

Moelv, Norway

Location

Pfizer Investigational Site

Oslo, Norway

Location

Pfizer Investigational Site

Mysłowice, Poland

Location

Pfizer Investigational Site

Warsaw, Poland

Location

Pfizer Investigational Site

Skövde, Sweden

Location

Pfizer Investigational Site

Stockholm, Sweden

Location

Pfizer Investigational Site

Balcali, Adana, Turkey (Türkiye)

Location

Pfizer Investigational Site

Samanpazarı, Ankara, Turkey (Türkiye)

Location

Pfizer Investigational Site

Balçova, İzmir, Turkey (Türkiye)

Location

Pfizer Investigational Site

Nr Lichfield, Staffordshire, United Kingdom

Location

Pfizer Investigational Site

Devon, United Kingdom

Location

Related Links

Study Officials

  • Pfizer CT.gov Call Center

    Pfizer

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 9, 2005

First Posted

September 22, 2005

Study Start

January 1, 2005

Primary Completion

March 1, 2006

Study Completion

March 1, 2006

Last Updated

November 7, 2012

Record last verified: 2012-11

Locations

DE(3)SE(2)TU(3)IT(2)GB(2)NO(2)US(46)AU(2)FR(1)CZ(2)CA(6)IL(4)PL(2)